[Myasthenia during interferon alpha therapy].
Quilichini
R
R
Mazzerbo
F
F
Baume
D
D
Amiel
O
O
Lafeuillade
A
A
Pellegrino
P
P
D000368:Aged; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006526:Hepatitis C / Q000188:drug therapy; D006521:Hepatitis, Chronic / Q000188:drug therapy; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D009157:Myasthenia Gravis / Q000139:chemically induced*
D000998:Antiviral Agents; D016898:Interferon-alpha
Myasthénie au cours d'un traitement par l'interféron alpha.